ENIGMATIG LTD EGG

Industrials SIC 8742 - Services-Management Consulting Services NAICS Professional, Scientific, and Technical Services › Management, Scientific, and Technical Consulting Services › Management Consulting Services › Administrative Management and General Management Consulting Services derived NYSE

Last close —
Market cap —
52-week range — - —

No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.

Valuation FY2025 figures against the last close

P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS0.02

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022
Revenue $4.5M$4.0M$4.6M—
Cost of revenue $1.4M$1.3M$1.5M—
Gross profit $3.1M$2.7M$3.1M—
Total operating expenses $2.5M$1.6M$1.7M—
Operating income $538.0K$1.0M$1.5M—
Pre-tax income $855.2K$963.4K$1.4M—
Income tax $295.5K$142.2K$242.6K—
Net income $559.7K$821.2K$1.1M—
EPS, basic 0.020.030.05—
EPS, diluted 0.020.030.05—
Shares, diluted (wtd. avg.) 25.9M25.0M25.0M—

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022
Cash and equivalents $13.2M$1.6M$1.2M$447.9K
Receivables $1.2M$1.1M——
Total current assets $15.1M$3.4M——
Property, plant and equipment $218.4K$731——
Total assets $18.2M$3.5M$4.0M—
Accounts payable $334.9K$328.0K——
Total current liabilities $1.8M$1.7M——
Total liabilities $2.2M$1.7M——
Retained earnings $2.1M$1.5M——
Total equity $16.0M$1.8M$812.7K-$344.8K

Cash flow

Fiscal year FY2025FY2024FY2023FY2022
Operating cash flow -$1.7M-$602.9K-$58.7K—
Depreciation and amortisation $33.0K$5.8K$1.7K—
Capital expenditure $246.1K$3.2K$4.1K—
Investing cash flow -$275.8K$1.9M$451.5K—
Financing cash flow $13.7M-$1.1M$347.3K—

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001493152-26-006963.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 2M 4M 6M Revenue, FY2023: 4.6M Gross profit, FY2023: 3.1M Net income, FY2023: 1.1M Revenue, FY2024: 4M Gross profit, FY2024: 2.7M Net income, FY2024: 821.2K Revenue, FY2025: 4.5M Gross profit, FY2025: 3.1M Net income, FY2025: 559.7K FY2022 FY2023 FY2024 FY2025
Fiscal year FY2022FY2023FY2024FY2025
Revenue — $4.6M $4.0M $4.5M
Gross profit — $3.1M $2.7M $3.1M
Net income — $1.1M $821.2K $559.7K

Others in SIC 8742

TickerCompanyMarket capP/ERevenue growth
BAH Booz Allen Hamilton Holding Corp $9.42B 11.4x -6.4%
G Genpact LTD $6.86B 13.0x 6.6%
FCN FTI CONSULTING, INC $4.34B 19.1x 2.4%
EXPO EXPONENT INC $3.68B 37.4x 4.2%
HURN Huron Consulting Group Inc. $3.17B 33.5x 11.9%
ASTH Astrana Health, Inc. $2.09B 81.4x 56.4%
ICFI ICF International, Inc. $1.69B 19.1x -7.3%
BWMN Bowman Consulting Group Ltd. $742.5M 58.7x 14.9%